![File:Hard metal lung disease Giant cell interstitial pneumonia (GIP) - Case 259 (8535265944).jpg - Wikimedia Commons File:Hard metal lung disease Giant cell interstitial pneumonia (GIP) - Case 259 (8535265944).jpg - Wikimedia Commons](https://upload.wikimedia.org/wikipedia/commons/4/4d/Hard_metal_lung_disease_Giant_cell_interstitial_pneumonia_%28GIP%29_-_Case_259_%288535265944%29.jpg)
File:Hard metal lung disease Giant cell interstitial pneumonia (GIP) - Case 259 (8535265944).jpg - Wikimedia Commons
![Innate Immune Modulation in Chronic Obstructive Pulmonary Disease: Moving Closer toward Vitamin D Therapy | Journal of Pharmacology and Experimental Therapeutics Innate Immune Modulation in Chronic Obstructive Pulmonary Disease: Moving Closer toward Vitamin D Therapy | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/353/2/360/F1.large.jpg)
Innate Immune Modulation in Chronic Obstructive Pulmonary Disease: Moving Closer toward Vitamin D Therapy | Journal of Pharmacology and Experimental Therapeutics
![Frontiers | Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment Frontiers | Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment](https://www.frontiersin.org/files/MyHome%20Article%20Library/494836/494836_Thumb_400.jpg)
Frontiers | Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment
![Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States - The Lancet Regional Health – Americas Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States - The Lancet Regional Health – Americas](https://www.thelancet.com/cms/attachment/0a6dab6b-0edc-406a-ae0d-5ef39064be4a/gr1.jpg)
Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States - The Lancet Regional Health – Americas
![Targeted Treatments for Chronic Obstructive Pulmonary Disease (COPD) Using Low-Molecular-Weight Drugs (LMWDs) | Journal of Medicinal Chemistry Targeted Treatments for Chronic Obstructive Pulmonary Disease (COPD) Using Low-Molecular-Weight Drugs (LMWDs) | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.8b01520/asset/images/large/jm-2018-01520k_0001.jpeg)